Summary This narrative review updates the 2021 Global Roadmap for tuberculosis (TB) vaccine research and development, assessing progress across three themes (pipeline diversification, preclinical/clinical acceleration...
1. Five years after the global TB vaccine roadmap launched, progress is real but painfully thin This narrative review updates the 2021 Global Roadmap for tuberculosis (TB) vaccine research and development, assessing...
Ebola virus disease (Bundibugyo, DRC) The Ebola outbreak due to the Bundibugyo virus in the Democratic Republic of the Congo continues to expand and is currently the most significant acute hemorrhagic fever emergency...
India — CDSCO digital submission mandate (effective 1 July) From 1 July 2026, India’s Central Drugs Standard Control Organization (CDSCO) requires that all Post-Approval Change applications for human vaccines and...
Marburg virus – Kyegegwa district, Uganda Uganda reported a confirmed Marburg virus disease case in the western Kyegegwa district, detected through enhanced surveillance related to the concurrent Bundibugyo Ebola...
Long COVID: an update for your medical practice Long COVID is best conceptualized as one or several post‑infectious syndromes: a disease with a known trigger (SARS‑CoV‑2 infection) that develops in only a definable...
Pregnancy is still a paradigmatic “stress test” for host defense against infection, but the picture has broadened considerably since the 2014 Kourtis review. The core message remains that pregnancy does not globally...
The UK Health Security Agency leaflet is a concise, well‑written guide to meningococcal group B (MenB) vaccination for teenagers and young adults in the UK. It explains in plain language why MenB matters, who is...
1. JN.1 booster shows surprising reach: cross-hits BA.3.2.2 and keeps a monoclonal option alive In this short immunogenicity study, 25 adults receiving a monovalent JN.1 mRNA vaccine provided serum before and about 12...
Combination and multivalent vaccines have always been the backbone of vaccination programs. An interim high appeared in the mid-1990ies when 6-valent DTaP combination vaccines were developed (DTaP-Hib-IPV-HBV)...